Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04794543 · ClinicalTrials.gov registry record
Effects of Using E-Cigarettes on Lungs in People With HIV (HBS Ancillary)
A clinical trial of HIV and Lung Injury, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- 23
- Enrollment target
- 2
- Study locations
NCT04794543 is a study of HIV and Lung Injury that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 23 participants, below the 440-participant average among 303 other HIV trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT04794543, a study of HIV and Lung Injury, has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- 23 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is an ancillary study, thus participants will be recruited from participants in the HBS Study. This project acutely assesses the role of the e-cigarettes and vaping on lung health. The proposed work will inform the design of future studies to better understand vaping's health consequences and to test novel interventions to mitigate vaping's contribution to acute and/or chronic lung injury.
Conditions Studied
Study Locations (2)
Louisiana
- Pennington Biomedical Research Center - Baton Rouge
- Lsuhsc-No - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2022-04-01 |
| Est. Completion | 2023-12-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04794543
The ClinicalTrials.gov registry entry for NCT04794543 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 303 other HIV trials with a reported enrollment target (95% lower). The listed sponsor is Pennington Biomedical Research Center, which has 258 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with HIV appearing as the primary indexed condition, and to 0 interventions.
NCT04794543 reports 2 study locations spanning 1 distinct geographic area - top geographies include Louisiana.
Frequently Asked Questions
What is clinical trial NCT04794543 about?
NCT04794543 is a clinical study titled "Effects of Using E-Cigarettes on Lungs in People With HIV (HBS Ancillary)". This is an ancillary study, thus participants will be recruited from participants in the HBS Study. This project acutely assesses the role of the e-cigarettes and vaping on lung health. The proposed work will inform the design of future studies to better understand vaping's health consequences and t...
What is the current status of trial NCT04794543?
This trial is currently completed. The enrollment target is 23 participants. The study started on 2022-04-01. Estimated completion is 2023-12-04.
What conditions does trial NCT04794543 study?
This clinical trial studies the following conditions: HIV, Lung Injury.
Who is sponsoring clinical trial NCT04794543?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04794543 being conducted?
This trial has 2 study locations across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Transitional Housing and HIV Health
RECRUITING
-
Clinical Trial to Evaluate the Safety and Immunogenicity of a Priming Regimen of 426c.Mod.Core-C4b Followed by HxB2.WT.Core-C4b Boosts, Both Adjuvanted With 3M-052 AF + Alum, in Adult Participants Without HIV and in Overall Good Health
RECRUITING · Phase 1
-
Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-1 Research Participants
RECRUITING
-
Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV
RECRUITING · Phase 2
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.